» Advanced search
Only first 10,000 results will be saved in the file.
No item is selected. Use checkboxes to select search results.
Displaying 1-25 of 934 results.
 
{{ selectedCountPage }} items selected on this page, {{ selectedCountPage }} item selected on this page, {{ selectedCountTotal }} item in total {{ selectedCountTotal }} items in total
and treatment of COVID-19 patients in Bojnurd Design: Shuffle block randomization Triple blinding (...) exclusion criteria: inclusion criteria Prophylactic study: Those who live with a Covid-19 patient in a single house. Have not had Covid-19 (or its symptoms) so far. Maximum 7 days have passed since start of
IRCTID: IRCT20150902023864N2
Study aim: Evaluation of early outcomes of liver transplantation from COVID-19 positive deceased donors and risk of transmission of COVID-19 in liver transplant Design: Non-randomized non-inferiority (...) hospital (COVID-19 center), in accordance with all health protocols, and the harvested liver will be
IRCTID: IRCT20200928048867N1
patients with COVID-19 2. Detection effect of Montelukast on duration of hospitalization, changes of (...) will give standard treatment of COVID-19 disease but test group will take Montelukast (Airokast, Abidi (...) exclusion criteria: Inclusion criteria: 1-All hospitalized patients with confirmed COVID-19 at both gender
IRCTID: IRCT20180624040213N2
from Covid-19 in improving clinical and laboratory symptoms of hospitalized patients Design: The (...) will be performed at Kosar hospital in Semnan. Convalescent plasma from COVID-19 recovered people will be injected to hospitalized patients suffering from COVID-19. Participants/Inclusion and exclusion
IRCTID: IRCT20151228025732N53
Study aim: Effect of Thalidomide on moderate COVID-19 pneumonia Design: Clinical trial with (...) performed in Taleghani Hospital in Tehran on patients with moderate pneumonia caused by Covid-19. Patients (...) laboratory results based on Covid-19, radiographic results indicating the presence of injury and lung
IRCTID: IRCT20210614051574N5
Study aim: Evaluating the efficacy of methylprednisolone mini pulse therapy on COVID-19 patients (...) which will be carried out on 60 hospitalized ‎COVID-19 patients. Settings and conduct: This clinical trial will be carried out on 60 hospitalized COVID-19 patients in Intensive care unit of imam Khomeini
IRCTID: IRCT20170716035126N4
Study aim: Determination of the effectiveness of Cyclotide complex in the prevention of COVID-19 virus after exposure to patients with COVID-19 and comparison with the control group Design: This (...) healthy individuals in exposure to a patient with COVID-19. Randomization will be by block randomization
IRCTID: IRCT20160131026298N4
in treatment of Covid-19 patients with ARDS Design: This study is a two arm parallel group, randomized clinical trial in phase 2 which will be carried out on 40 hospitalized ‎COVID-19 patients (...) on 40 hospitalized COVID-19 patients in Intensive care unit of imam Reza hospital of AJA university
IRCTID: IRCT20200406046963N2
Study aim: Investigate the effect of interactive digital-based psychoeducational intervention about COVID-19 on knowledge, fear, and anxiety among secondary school students Design: A quasi-experimental (...) May 2022 Main outcome variables: Covid-19 related knowledge, fear, and anxiety
IRCTID: IRCT20210612051555N2
  1. Design, Implementation and Evaluation of an Educational Intervention Based on Health Belief Model in COVID-19 Preventive Behaviors among teachers
  2. COVID-19 Pandemic: Effect of Digital-Based Educational Intervention Using Protection Motivation Theory on Saudi Electronic University students' knowledge and self-protective behaviors
  3. Effect of two educational methods- educational software and booklet- on knowledge, attitude and performance of adolescent girls regarding puberty hygiene: a randomized controlled trial.
  4. A comparative study of the effect of two educational methods (pamphlet and virtual viedio) on the level of awareness of coping strategies with corona virus in high school students
  5. Comparion of Effect of Puberty Health Education to Mothers and Daughters on Girls’ Knowledge and Performance in High Schools of Tabriz:Single Blind Randomized Clinical Trial
  6. The Impact of Educational Intervention by Interactional Multi Media based on Health belief model on preventive behavior about pediculosis in primary school students
  7. Designing, implementing, and evaluating of educational program based on a Multi-Theory Model regarding preventive behaviors of Covid-19 in students
  8. The Effect of Patient Education Through Social Media on COVID-19-Related Fear, Anxiety, and Self-care in Diabetes Patients
  9. To assess the efficacy of teaching and training techniques to improve the resilience of nurses in the COVID-19 pandemic
  10. The Effectiveness of Cognitive-Behavioral Stress Management education on the improvement of self efficacy and academic Stress Caused by Personal and Parental Expectations among High School Students of Jiroft, in 2018.
positive test for COVID-19 virus Design: This study is a double blind clinical trial which has two (...) nominated by a code will be gave to the patients and after 5 days the COVID-19 RtPCR will be done on the (...) . Participants/Inclusion and exclusion criteria: Every patient with positive COVID-19 PCR and positive regard for
IRCTID: IRCT20181208041886N2
with COVID-19 in Bu Ali Sina Hospital in Qazvin in 2021 Design: A double-blind randomized clinical (...) used for randomization. Settings and conduct: The study population is patients with COVID-19 admitted to Bouali sina Hospital in Qazvin in 2021 who has developed COVID-19 pneumonia and pulmonary
IRCTID: IRCT20210710051831N1
with COVID-19 Design: The randomized clinical trial, parallel groups, 200 patients will be enrolled (...) will be prescribed standard regimen for COVID-19. Patients in Metformin group will be prescribed Metformin 500 mg BID for two weeks and standard regimen for COVID-19. The routine lab data, hospitalization
IRCTID: IRCT20160310026998N11
Study aim: Evaluation the efficacy and safety of Hydroxychloroquine administration for COVID-19 (...) over 18 years old and had a close contact with a COVID-19 case at least in past 4 days and signed the informed consent form included. Also, pervious cases of COVID-19 and who had flu like symptoms or those
IRCTID: IRCT20130917014693N10
  1. A Randomized, Multi-centric, Double-blind, Placebo-controlled study to Evaluate the Efficacy and Safety of Bromhexine, a serine protease (TMPRSS2) blocker, to prevent COVID-19
  2. Evaluation the efficacy and safety of Umifenovir (Arbidol) Administration in comparison with Lopinavir-ritonavir (Kaletra) in COVID-19 patients
  3. Evaluate the efficacy of hydroxychloroquine in the prevention of SARS-COV2 infection in high risk health care workers
  4. Evaluation of the efficacy and safety of oral pentoxifylline in treatment and recovery of patients with COVID-19 admitted in Rasoul Akram and firoozgar hospitals treated with routine protocols, A randomized controlled clinical trial
  5. Evaluation of the efficacy and safety of Umifenovir in the treatment of hospitalized patients with covid-19: A randomized clinical trial
  6. Evaluation the efficacy and safety of Sitagliptin administration in patients with COVID-19
  7. Safety evaluation of a quadrivalent recombinant influenza vaccine (serotypes of 2021/2022) manufactured by Nivad Pharmed Salamat, open label, single arm, in volunteers aged ≥ 18 years.
  8. Evaluating effectiveness and safety of Umifenovir in the treatment (COVID-19)infection In patients referred to Tehran Imam Khomeini Hospital Complex
  9. Investigating the efficacy and safety of Hydroxychloroquine nasal spray in controlling the symptoms of patients with COVID-19
  10. Evaluation of safety and efficacy of hydroxychloroquine plus favipiravir drug regimen in comparison with hydroxychloroquine plus kaletra on the need for intensive care unit treatment in patients with COVID-19; a randomized, multicenter, parallel groups, open label study
which will be carried out on 40 hospitalized ‎COVID-19 patients. Patients randomly divided into two groups. Settings and conduct: This clinical trial will be carried out on 40 hospitalized COVID-19 (...) criteria: Inclusion Criteria: Patients admitted to ICU with moderate to severe Covid-19 infection needs
IRCTID: IRCT20200406046963N1
improving pulmonary function, exercise tolerance and quality of life in Covid 19 survivors Design: Quasi (...) exclusion criteria: COVID-19 survivors (i.e., diagnosed with COVID-19, have had respiratory illness and (...) informed consent document. Hemoglobin of 9.0 gm/dl or higher COVID-19 Survivor Group documented prior COVID
IRCTID: IRCT20211224053506N1
Study aim: Evaluation of the effectiveness of intravenous infusion of human COVID-19 hyperimmune plasma with specific antibody titer in hospitalized patients with Covid-19: a randomized clinical trial (...) COVID-19 pneumonia based on PCR or pulmonary imaging; Presenting clinical symptoms of COVID-19 (fever
IRCTID: IRCT20201004048922N1
of Patients with COVID-19 Design: Clinical trial with control group with parallel groups without (...) with definit diagnosis of COVID-19, Random allocation is done using a random sequence generated by the (...) patients with COVID-19 referring to the emergency departments of COVID hospitals in Najaf. No blinding will
IRCTID: IRCT20140625018231N1
patients with COVID-19 Design: The randomized clinical trial with a parallel group design in which 200 (...) standard regimen for COVID-19. Patients in Metformin group will be prescribed Metformin 500 mg BID for two weeks and standard regimen for COVID-19. The routine lab data, need for hospitalization and mortality
IRCTID: IRCT20160310026998N10
Lopinavir-ritonavir in COVID-19 patients Design: Clinical trial with parallel randomized groups Settings (...) study, patients who were between 18 and 100 years old, confirmed COVID-19 with RT-PCR, and signed the (...) liver disease, mild cases of COVID-19 (outpatients) or critical cases of COVID-19 (needs to ICU or
IRCTID: IRCT20151227025726N15
Study aim: Reduce the infection with covid-19 and mortality of staff due to covid-19 with favipiravir treatment during the Covid- 19 epidemic. Design: Thirty people in the intensive care unit who (...) . Settings and conduct: Thirty ICU staff who are in direct contact with Covid-19 positive patients have been
IRCTID: IRCT20150107020592N30
patients with respiratory failure caused by the COVID-19 Design: Clinical trial with one intervention group, with no control group and no blindness on 40 hospitalized patients with severe forms of COVID-19 (...) patients with severe forms of COVID-19. Inclusion Criteria: Patients with diagnosis of COVID-19 based on
IRCTID: IRCT20200608047686N2
Study aim: Evaluating the IL-6 level in COVID-19 patients hospitalized in Intensive Care Unit (ICU), after consuming Fluvoxamine. Comparing the IL-6 level in two groups of COVID-19 patients, hospitalized (...) Massih Daneshvari Hospital, which 40 hospitalized patients in ICU ward due to COVID-19 are selected by
IRCTID: IRCT20131115015405N4
Study aim: Evaluation of prophylaxis induced by ivermectin in populations exposed to COVID-19 patients to provide a safe and low-cost way to cure or lowering the consequences of COVID-19 Design: Phase (...) : Inclusion: Healthy individuals exposed directly and constantly with COVID-19 patients. COVID-19 patients who
IRCTID: IRCT20200408046987N3
Study aim: Evaluation of safety and efficacy of FLUVAR® in prevention of COVID-19 compared to (...) volunteers at risk of COVID-19 Blinding: The researcher is unaware of which drug or placebo is being (...) - Participating in another clinical trial for COVID-19 Intervention groups: FLUVAR® nasal spray group 500µl once
IRCTID: IRCT20200404046932N2
  1. Efficacy evaluation of FLUVAR® in the onset of the disease with symptoms of respiratory infection synonymous with the symptoms of COVID-19 in patients referred to emergency departments and clinics
  2. Evaluation safety and efficacy of herbal combination IMPOHelzavid on improving the symptoms of patients with COVID-19: A placebo controlled double-blind clinical study
  3. Evaluation of Convalescent Plasma as a Potential Therapy for COVID-19 infected patients
  4. A double-blind, randomized, placebo-controlled Phase II/III Clinical trial to evaluate the safety and efficacy of COVID-19 inactivated vaccine (Shifa-Pharmed) in a population aged 18 to 75 years
  5. Evaluation of short term outcomes of liver transplantation from COVID-19 positive deceased donors
  6. Safety and immunogenicity of SARS-CoV-2 inactivated vaccine (OSVID-19) in healthy volunteers aged 18 to 40 years: A clinical trial, phase 1, single arm
  7. Clinical trial of ealuation of phage therapy with nebulizer in prevention of secondary bacterial pneumonia in admitted patients with moderate to severe COVID-19
  8. Study of the safety of hyperimmune bovine milk and colostrum against covid-19
  9. Efficacy, safety, and immunogenicity of Soberana recombinant vaccine (product of Finlay Institute) based on RBD protein subunit of Sars-Cov-2 in a 2-dose regimen with and without a booster dose: a double-blind, randomized, placebo-controlled phase III clinical trial in the Iranian population of 18-80 years
  10. Safety and Immunogenicity of Razi Cov-2 recombinant Spike protein vaccine (RAZI Cov Pars) in healthy adolescents aged 12-17 years; single group, open label study
COVID-19 Design: Clinical trial with controlled group, parallel design, double-blinded, multi-centric (...) informed consent; Age of 18 years or more; Exposure and close contact with a COVID-19 patients within 4 (...) for prophylaxis or treatment if COVID-19; patients with any sign and symptoms of COVID-19
IRCTID: IRCT20120703010178N22
Loading...